This term denotes therapeutic strategies aimed at mitigating the negative physiological impact of senescent cells, which are cells that have ceased dividing but remain metabolically active, secreting pro-inflammatory factors. Within hormonal health, senescence contributes to tissue resistance to trophic factors and age-related decline in endocrine function. Intervention seeks to clear these dysfunctional cells or neutralize their detrimental secretome, often termed the Senescence-Associated Secretory Phenotype (SASP).
Origin
The concept arises from gerobiology and molecular pathology, identifying cellular aging as a core driver of pathology, distinct from simple cell death. Intervention implies the application of senolytic or senomorphic agents to restore tissue homeostasis. This area of study links directly to understanding how aging affects the hypothalamic-pituitary axes.
Mechanism
Intervention mechanisms often involve targeting specific survival pathways unique to senescent cells, leading to their selective apoptosis (senolysis). Alternatively, senomorphic approaches aim to suppress the inflammatory cytokines released by these cells, thereby reducing chronic, low-grade inflammation that disrupts normal endocrine signaling. Successful intervention supports the renewal capacity of healthy progenitor populations.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.